This translocation causes expression of the BCR-ABL fusion protein, a tyrosine kinase with constitutively increased kinase activity [3] which is thought to be necessary and sufficient for the initiation of CML [4]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.